Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Dosage form having a saccharide matrix

A dosage form and matrix technology, applied in the field of non-compressible rapidly dispersing solid dosage forms

Inactive Publication Date: 2006-04-12
ALK ABELLO SA
View PDF16 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is no disclosure on how to achieve the goal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0264] grass extract

[0265] Grass pollen extract according to Ipsen and L Prepared as described in wensten (1983) Jour. Allergy. Clin. Immunol. 72:2, pp. 150-159. Briefly, grass pollen was extracted in ammonium bicarbonate at 5°C for 20 hours. Particulate matter was removed by centrifugation and the supernatant was dialyzed 3 times against water, freeze-dried and stored under refrigerated conditions until reconstitution.

[0266] Solid dosage form:

[0267] Manufacturing process:

[0268] 1. MQ water is added to a beaker with a magnetic stirrer,

[0269] 2. Mannitol and Sorbitol, if desired, are added and dissolved under stirring,

[0270] 3. Maltodextrin and PEG, if required, are added and dissolved under stirring,

[0271] 4. Allergen extracts, if desired, are added,

[0272] 5. If the allergen is present, the pH is adjusted to pH=7-8, and adjusted with hydrochloric acid (2N) or sodium hydroxide (2N),

[0273] 6. Under ambient temperature conditions, 250 μl of the...

Embodiment 5

[0292] This example relates to the preparation of a granular composition of granules having a matrix consisting of mannitol, maltodextrin and sorbitol, wherein the matrix contains microencapsulated allergens (MEA), this example also It relates to the preparation of compressed tablets from a granular composition.

[0293] Material

[0294] Encapsulant: Poly-D,L-lactide-glycolide (DL-PLG) (60 / 40) with MW 40,000 g / mol obtained from Birmingham Polymers, USA.

[0295] Active substance: MEA-Phlp extract in the form of granules

[0296] Mannitol: Ph. Eur. , No. 281048, from Unikem.

[0297] Sorbitol: Ph. Eur. , No. 340927, from Nomeco.

[0298] Maltodextrin: NF 18, type CPUR01915(18DE) from Cerestar.

[0299] Talc: Ph. Eur. , No. 297911, from Unikem.

[0300] Magnesium Stearate: Ph. Eur. , No. 280560, from Unikem.

[0301] Test methods for compressed tablets

[0302] Stress resistance

[0303] The tablets are placed horizontally on the support against the first vertical plat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a non-compressed fast-dispersing solid dosage form suitable for oromucosal administration of a pharmaceutically active substance comprising (a) a first matrix forming agent in the form of maltodextrin having a dextrose equivalent (DE) of between 1 and 20,(b) a second matrix forming agent in the form of sorbitol, and (c) the active substance.

Description

technical field [0001] The present invention relates to non-compressible fast-dispersing solid dosage forms suitable for the administration of pharmaceutically active substances and for the manufacture of compressed fast-dispersing tablets. Background of the invention [0002] Allergies are a major health problem in countries adapted to a Western lifestyle. Furthermore, the prevalence of allergic diseases is increasing in these countries. Although allergies are generally not considered life-threatening diseases, asthma causes a significant number of deaths each year. The abnormal prevalence of approximately 30% among adolescents results in significant losses in quality of life, working time and money, and secures a classified place among the major health problems in the Western world. [0003] Allergies are complex diseases. Many factors contribute to hypersensitivity events. Among these are individual susceptibilities determined by the interaction of several genes which...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/00A61K39/35A61K47/26A61K47/36A61K47/42A61K9/19A61K9/20A61K39/36
CPCA61K2039/542A61K9/2059A61K9/2018A61K39/36A61K9/19A61K9/006A61K39/35
Inventor C·G·赫格顿A·R·伦德迦德
Owner ALK ABELLO SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com